128 related articles for article (PubMed ID: 7271828)
1. Influence of harmaline on the ability of pargyline to alter catecholamine metabolism in rats.
Fuller RW; Hemrick-Luecke SK; Perry KW
Biochem Pharmacol; 1981 Jun; 30(11):1295-8. PubMed ID: 7271828
[No Abstract] [Full Text] [Related]
2. Depletion of epinephrine in rat hypothalamus by Ro 4-1284: influence of pargyline and harmaline.
Fuller RW; Hemrick-Luecke SK
Brain Res Bull; 1980; 5(5):589-91. PubMed ID: 6903452
[TBL] [Abstract][Full Text] [Related]
3. MD 240928 and harmaline: opposite selectivity in antagonism of the inactivation of types A and B monoamine oxidase by pargyline in mice.
Fuller RW; Wong CJ; Hemrick-Luecke SK
Life Sci; 1986 Feb; 38(5):409-12. PubMed ID: 3945167
[TBL] [Abstract][Full Text] [Related]
4. Enhanced selectivity of pargyline as an inhibitor of type B monoamine oxidase in harmaline-treated rats.
Fuller RW; Hemrick SK
Life Sci; 1978 Mar; 22(12):1083-6. PubMed ID: 642716
[No Abstract] [Full Text] [Related]
5. Effects of different monoamine oxidase inhibitors on the metabolism of L-dopa in the rat brain.
Nguyen TB; Angers M
Biochem Pharmacol; 1987 May; 36(10):1731-5. PubMed ID: 3109430
[TBL] [Abstract][Full Text] [Related]
6. Uptake and metabolism of catecholamines in rat brain synaptosomes: studies on the contribution of monoamine oxidase.
Urwyler S; von Wartburg JP
Biochem Pharmacol; 1981 Oct; 30(20):2777-85. PubMed ID: 7332636
[No Abstract] [Full Text] [Related]
7. Catecholamine degradation by monoamine oxidase in locus coeruleus neurons of the rat. An immunohistochemical study.
Kishimoto Y; Geffard M; Arai R
Brain Res; 2000 Mar; 859(2):373-7. PubMed ID: 10719089
[TBL] [Abstract][Full Text] [Related]
8. Application of steady-state kinetics to the study of catecholamine turnover after monoamine oxidase inhibition or reserpine administration.
Neff NH; Costa E
J Pharmacol Exp Ther; 1968 Mar; 160(1):40-7. PubMed ID: 5639109
[No Abstract] [Full Text] [Related]
9. Effect of monoamine oxidase inhibition on catecholamine levels: evidence for synthesis but not storage of epinephrine in rat spinal cord.
Sved AF
Brain Res; 1990 Apr; 512(2):253-8. PubMed ID: 2354362
[TBL] [Abstract][Full Text] [Related]
10. Lowering of dopamine metabolites in rat brain by harmaline.
Fuller RW; Hemrick-Luecke SK; Perry KW
J Pharm Pharmacol; 1981 Apr; 33(4):255-6. PubMed ID: 6115915
[No Abstract] [Full Text] [Related]
11. Evidence for inhibition of monoamine oxidase in vivo in rat brain by 7,8-dichloro-1,2,3,4-tetrahydroisoquinoline.
Fuller RW; Hemrick-Luecke SK
Res Commun Chem Pathol Pharmacol; 1983 Mar; 39(3):519-22. PubMed ID: 6856953
[TBL] [Abstract][Full Text] [Related]
12. Catecholamine metabolism in pargyline treated rats exposed to stress.
Prasad R; Patel V; Chansouria JP; Udupa KN
Endocrinol Exp; 1980; 14(2):147-50. PubMed ID: 6104592
[TBL] [Abstract][Full Text] [Related]
13. The influence of pargyline on the storage and release of dopamine from the cat spleen.
Farmer JB; Roberts DJ; Street DM
Arch Int Pharmacodyn Ther; 1971 Apr; 190(2):309-15. PubMed ID: 5575584
[No Abstract] [Full Text] [Related]
14. Differential Susceptibilities of Catecholamines to Metabolism by Monoamine Oxidases.
Goldstein DS; Castillo G; Sullivan P; Sharabi Y
J Pharmacol Exp Ther; 2021 Nov; 379(3):253-259. PubMed ID: 34503991
[TBL] [Abstract][Full Text] [Related]
15. Antagonism between harmaline and longacting monoamine oxidase inhibitors concerning the effect on 5-hydroxytryptamine and norepinephrine metabolism in the brain.
PLETSCHER A; BESENDORF H
Experientia; 1959 Jan; 15(1):25-6. PubMed ID: 13619675
[No Abstract] [Full Text] [Related]
16. Facilitatory and inhibitory effects of harmaline on the tryptophan-induced 5-hydroxytryptamine syndrome and body temperature changes in pargyline-pretreated rats.
Abdel-Fattah AF; Matsumoto K; Murakami Y; El-Hady KA; Mohamed MF; Watanabe H
Jpn J Pharmacol; 1996 Sep; 72(1):39-47. PubMed ID: 8902598
[TBL] [Abstract][Full Text] [Related]
17. The role of monoamine oxidase in catecholamine-stimulated prostaglandin biosynthesis of rat brain homogenates.
Komlós M; Seregi A; Schaefer A
J Pharm Pharmacol; 1980 Aug; 32(8):592-3. PubMed ID: 6106705
[No Abstract] [Full Text] [Related]
18. Uptake and storage of catecholamines in mucosal mast cells of the rat.
Enerbäck L; Häggendal J
J Histochem Cytochem; 1970 Nov; 18(11):803-11. PubMed ID: 5511127
[No Abstract] [Full Text] [Related]
19. Selective monoamine oxidase inhibitor drugs as aids in evaluating the role of type A and B enzymes.
Fuentes JA; Neff NH
Neuropharmacology; 1975 Nov; 14(11):819-25. PubMed ID: 1207877
[No Abstract] [Full Text] [Related]
20. Rapid effects of monoamine oxidase inhibitors on synthesis and release of central monoamines.
Glowinski J; Hamon M; Javoy F; Morot-Gaudry Y
Adv Biochem Psychopharmacol; 1972; 5():423-39. PubMed ID: 4403372
[No Abstract] [Full Text] [Related]
[Next] [New Search]
